|
ACT Lung Health Intervention: Phase Two
RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2025-11-04
Est. completion2026-09-30
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT06945120
Summary
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Eligibility
Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: * Self-identify as either Chinese or Korean * Speak either Korean, Mandarin, or English * Eligible for LDCT screening (50-80 years of age and 20- pack-year smoking history) * Currently smoking (i.e., having smoked within the prior 30 days), * Currently have active health insurance coverage and a primary healthcare provider and * Have access to a video-call device with internet or wireless connection. * Eastern Cooperative Oncology Group functional status \<2 * Live in the United States for the next 12 months Exclusion Criteria: * Had LDCT screening done within the last 2 years. * Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months. * Previous history of lung cancer. * We will not include any of the following special populations: * Adults unable to consent. * Adults younger than 50 or older than 80 years * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners
Conditions7
CancerLung CancerSmoking (Tobacco) AddictionSmoking BehaviorsSmoking CessationSmoking, CigaretteSmoking, Tobacco
Locations2 sites
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2025-11-04
Est. completion2026-09-30
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT06945120